322 related articles for article (PubMed ID: 9671368)
1. Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome.
Kiehl MG; Ostermann H; Thomas M; Müller C; Cassens U; Kienast J
Crit Care Med; 1998 Jul; 26(7):1194-9. PubMed ID: 9671368
[TBL] [Abstract][Full Text] [Related]
2. Infections and the inflammatory response in acute respiratory distress syndrome.
Headley AS; Tolley E; Meduri GU
Chest; 1997 May; 111(5):1306-21. PubMed ID: 9149588
[TBL] [Abstract][Full Text] [Related]
3. Leukocytes in ARDS--a minor role in a big symphony orchestra?
Suter PM
Crit Care Med; 1998 Jul; 26(7):1151-2. PubMed ID: 9671356
[No Abstract] [Full Text] [Related]
4. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome.
Armstrong L; Millar AB
Thorax; 1997 May; 52(5):442-6. PubMed ID: 9176536
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.
Schütte H; Lohmeyer J; Rosseau S; Ziegler S; Siebert C; Kielisch H; Pralle H; Grimminger F; Morr H; Seeger W
Eur Respir J; 1996 Sep; 9(9):1858-67. PubMed ID: 8880103
[TBL] [Abstract][Full Text] [Related]
6. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model.
Steinberg J; Halter J; Schiller H; Gatto L; Carney D; Lee HM; Golub L; Nieman G
Shock; 2005 Oct; 24(4):348-56. PubMed ID: 16205320
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators in BAL fluid as markers of evolving pneumonia in leukocytopenic patients.
Kiehl MG; Ostermann H; Thomas M; Birkfellner T; Kienast J
Chest; 1997 Nov; 112(5):1214-20. PubMed ID: 9367460
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival.
Lesur O; Kokis A; Hermans C; Fülöp T; Bernard A; Lane D
Crit Care Med; 2000 Dec; 28(12):3814-22. PubMed ID: 11153619
[TBL] [Abstract][Full Text] [Related]
9. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury.
Donnelly TJ; Meade P; Jagels M; Cryer HG; Law MM; Hugli TE; Shoemaker WC; Abraham E
Crit Care Med; 1994 May; 22(5):768-76. PubMed ID: 8181284
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome.
Meduri GU; Kohler G; Headley S; Tolley E; Stentz F; Postlethwaite A
Chest; 1995 Nov; 108(5):1303-14. PubMed ID: 7587434
[TBL] [Abstract][Full Text] [Related]
11. Cytokine balance in the lungs of patients with acute respiratory distress syndrome.
Park WY; Goodman RB; Steinberg KP; Ruzinski JT; Radella F; Park DR; Pugin J; Skerrett SJ; Hudson LD; Martin TR
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1896-903. PubMed ID: 11734443
[TBL] [Abstract][Full Text] [Related]
12. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome.
Donnelly SC; Strieter RM; Reid PT; Kunkel SL; Burdick MD; Armstrong I; Mackenzie A; Haslett C
Ann Intern Med; 1996 Aug; 125(3):191-6. PubMed ID: 8686976
[TBL] [Abstract][Full Text] [Related]
13. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.
Montón C; Torres A; El-Ebiary M; Filella X; Xaubet A; de la Bellacasa JP
Crit Care Med; 1999 Sep; 27(9):1745-53. PubMed ID: 10507593
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS.
Jorens PG; Van Damme J; De Backer W; Bossaert L; De Jongh RF; Herman AG; Rampart M
Cytokine; 1992 Nov; 4(6):592-7. PubMed ID: 1292643
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.
Goodman RB; Strieter RM; Martin DP; Steinberg KP; Milberg JA; Maunder RJ; Kunkel SL; Walz A; Hudson LD; Martin TR
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):602-11. PubMed ID: 8810593
[TBL] [Abstract][Full Text] [Related]
16. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS.
Meduri GU; Headley S; Tolley E; Shelby M; Stentz F; Postlethwaite A
Chest; 1995 Nov; 108(5):1315-25. PubMed ID: 7587435
[TBL] [Abstract][Full Text] [Related]
17. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.
Ranieri VM; Suter PM; Tortorella C; De Tullio R; Dayer JM; Brienza A; Bruno F; Slutsky AS
JAMA; 1999 Jul; 282(1):54-61. PubMed ID: 10404912
[TBL] [Abstract][Full Text] [Related]
18. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis.
Raymondos K; Leuwer M; Haslam PL; Vangerow B; Ensink M; Tschorn H; Schürmann W; Husstedt H; Rueckoldt H; Piepenbrock S
Crit Care Med; 1999 Jan; 27(1):82-9. PubMed ID: 9934898
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A Is Associated With Alveolar Inflammation and Poor Outcomes in Acute Respiratory Distress Syndrome.
Mikacenic C; Hansen EE; Radella F; Gharib SA; Stapleton RD; Wurfel MM
Crit Care Med; 2016 Mar; 44(3):496-502. PubMed ID: 26540401
[TBL] [Abstract][Full Text] [Related]
20. Bronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients.
Stapleton RD; Suratt BT; Neff MJ; Wurfel MM; Ware LB; Ruzinski JT; Caldwell E; Hallstrand TS; Parsons PE
Biomarkers; 2019 Jun; 24(4):352-359. PubMed ID: 30744430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
